Body fat phenotypes and treatment response to spironolactone in ambulatory patients with heart failure and preserved ejection fraction: a post‐hoc analysis of the Aldo‐DHF trial - Université de Lorraine Access content directly
Journal Articles European Journal of Heart Failure Year : 2020

Body fat phenotypes and treatment response to spironolactone in ambulatory patients with heart failure and preserved ejection fraction: a post‐hoc analysis of the Aldo‐DHF trial

Dates and versions

hal-02865493 , version 1 (11-06-2020)

Identifiers

Cite

Johannes Petutschnigg, Joao Pedro Ferreira, Volker Holzendorf, Tobias Trippel, Djawid Hashemi, et al.. Body fat phenotypes and treatment response to spironolactone in ambulatory patients with heart failure and preserved ejection fraction: a post‐hoc analysis of the Aldo‐DHF trial. European Journal of Heart Failure, 2020, 22 (3), pp.559-561. ⟨10.1002/ejhf.1723⟩. ⟨hal-02865493⟩
37 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More